--- title: "EFS, Early Feasibility Study | MedTech Terms" description: "FDA program enabling early human evaluation of novel devices with limited preclinical data and iterative design." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/efs#term", "name": "Early Feasibility Study", "alternateName": "EFS", "description": "EFSs allow first-in-human use of a novel device based on less nonclinical evidence than a traditional IDE, with allowances for iterative device modifications during the study.", "url": "https://medtechterms.com/terms/efs", "termCode": "efs", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/efs#article", "headline": "EFS, Early Feasibility Study", "description": "FDA program enabling early human evaluation of novel devices with limited preclinical data and iterative design.", "url": "https://medtechterms.com/terms/efs", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/efs" }, "about": { "@id": "https://medtechterms.com/terms/efs#term" }, "articleSection": "Clinical & Trials", "inLanguage": "en", "keywords": "Early Feasibility Study, EFS, Clinical & Trials, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "FDA EFS Guidance", "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-device-exemptions-ides-early-feasibility-medical-device-clinical-studies-including", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "ISO 14155 Standard Page", "url": "https://www.iso.org/standard/71690.html", "publisher": { "@type": "Organization", "name": "ISO" } }, { "@type": "CreativeWork", "name": "FDA - Clinical Trials and Human Subject Protection", "url": "https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection", "publisher": { "@type": "Organization", "name": "FDA" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/fih#term", "name": "First-in-Human Study", "alternateName": "FIH", "url": "https://medtechterms.com/terms/fih" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/ide#term", "name": "Investigational Device Exemption", "alternateName": "IDE", "url": "https://medtechterms.com/terms/ide" }, { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/feasibility-study#term", "name": "Feasibility Study", "url": "https://medtechterms.com/terms/feasibility-study" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Clinical & Trials", "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials" }, { "@type": "ListItem", "position": 4, "name": "Early Feasibility Study", "item": "https://medtechterms.com/terms/efs" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/efs#faq", "mainEntity": [ { "@type": "Question", "name": "What is the primary goal of an Early Feasibility Study?", "acceptedAnswer": { "@type": "Answer", "text": "The primary goal is to gather initial clinical experience with a novel medical device, often a first-in-human use, to inform device design and development. It aims to evaluate the device's safety and basic functionality in a limited patient population." } }, { "@type": "Question", "name": "How does an EFS differ from a traditional IDE study?", "acceptedAnswer": { "@type": "Answer", "text": "An EFS typically involves less extensive non-clinical evidence to support the initial human use and allows for iterative device modifications during the study. Traditional IDEs generally require more comprehensive non-clinical data and have less flexibility for design changes during the trial." } }, { "@type": "Question", "name": "Can device modifications be made during an EFS?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, a key feature of an EFS is the allowance for iterative device modifications based on early clinical feedback, which can be implemented more readily than in traditional clinical trials. These modifications must be documented and reviewed according to the study protocol and regulatory requirements." } }, { "@type": "Question", "name": "Is an EFS always a first-in-human study?", "acceptedAnswer": { "@type": "Answer", "text": "While often a first-in-human study, an EFS may also involve early clinical experience with a modification to an existing device for a new indication or patient population, where the modification significantly changes the device's safety or performance characteristics." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials) 6. / 7. Early Feasibility Study [All terms](/terms) Clinical & Trials [Clinical Evidence](/ecosystems/clinical-evidence)[Global Markets](/ecosystems/global-markets)[Startup Lifecycle](/ecosystems/startup-lifecycle)EFS # Early Feasibility Study FDA program enabling early human evaluation of novel devices with limited preclinical data and iterative design. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition EFSs allow first-in-human use of a novel device based on less nonclinical evidence than a traditional [IDE](/terms/ide), with allowances for iterative device modifications during the study. What the regulation says The FDA provides specific guidance on Early Feasibility Studies, outlining criteria for device selection, non-clinical data requirements, and the iterative nature of device modifications. This approach is intended to accelerate the development of novel medical devices by allowing earlier human experience (FDA, "Guidance for Industry and FDA Staff: Early Feasibility Studies for Medical Devices"). ## What this means in practice Strategically valuable for breakthrough cardiovascular, neuro, and surgical devices needing early clinical signal to inform design freeze. ## Examples - A MedTech company is developing a novel neurostimulation device for refractory epilepsy and conducts an EFS to assess its initial safety and thermodynamic stability in a small cohort of patients. - An EFS is initiated for a new cardiovascular stent design to evaluate acute deployment success and early patency rates, allowing real-time adjustments to the delivery system. - A surgical robotics firm performs an EFS to test a new haptic feedback system in real surgical scenarios, making minor software adjustments based on surgeon input. Common pitfalls - • A common pitfall is misunderstanding the reduced non-clinical evidence requirements, which are still substantial and must justify the proposed human use. - • Another mistake is failing to adequately plan for iterative device modifications, leading to delays in regulatory approvals. - • Companies often underestimate the importance of strong clinical protocol design and robust data collection in EFSs. - • Inadequate consideration of patient safety measures during the iterative design process can lead to serious compliance issues. ## Frequently asked questions What is the primary goal of an Early Feasibility Study? The primary goal is to gather initial clinical experience with a novel medical device, often a first-in-human use, to inform device design and development. It aims to evaluate the device's safety and basic functionality in a limited patient population. How does an EFS differ from a traditional IDE study? Can device modifications be made during an EFS? Is an EFS always a first-in-human study? ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Clinical & Trials Feasibility Study Small clinical study evaluating initial safety, usability, and design parameters of an investigational device. ](/terms/feasibility-study)[ Clinical & Trials First-in-Human Study(FIH) First clinical use of a device or therapy in humans, often outside the U.S. before a U.S. EFS. ](/terms/fih)[ Clinical & Trials Investigational Device Exemption(IDE) FDA authorization to use an investigational device in a clinical study. ](/terms/ide) ### More in Clinical & Trials · Same category [ Clinical & Trials Adaptive Trial Design Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data. ](/terms/adaptive-trial)[ Clinical & Trials Adverse Event(AE) Any untoward medical occurrence in a subject, whether or not related to the device. ](/terms/adverse-event)[ Clinical & Trials ALCOA+ Data integrity principles: Attributable, Legible, Contemporaneous, Original, Accurate (plus Complete, Consistent, Enduring, Available). ](/terms/alcoa-plus)[ Clinical & Trials Analytical Sensitivity An IVD's ability to detect small quantities of an analyte. ](/terms/analytical-sensitivity) Cited by Where this term appears across MedTech Terms. Ecosystems (3) - [Clinical Evidence](/ecosystems/clinical-evidence) - [Global Markets](/ecosystems/global-markets) - [Startup Lifecycle](/ecosystems/startup-lifecycle) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 FDA· 2 ISO· 1 1. [1 FDA EFS Guidance Verified FDA · fda.gov ](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-device-exemptions-ides-early-feasibility-medical-device-clinical-studies-including) 2. [2 ISO 14155 Standard Page Verified ISO · iso.org ](https://www.iso.org/standard/71690.html) 3. [3 FDA - Clinical Trials and Human Subject Protection Verified FDA · fda.gov ](https://www.fda.gov/science-research/science-and-research-special-topics/clinical-trials-and-human-subject-protection) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Clinical evidence intersecting with device security? We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Clinical & Trials Acronym EFS Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=efs) Learn in 60 seconds Card Lesson Quiz FDA program enabling early human evaluation of novel devices with limited preclinical data and iterative design. - · Strategically valuable for breakthrough cardiovascular, neuro, and surgical devices needing early clinical signal to inform design freeze. Remember this Watch out: A common pitfall is misunderstanding the reduced non-clinical evidence requirements, which are still substantial and must justify the proposed human use. Related terms - [First-in-Human Study(FIH) ](/terms/fih) - [Investigational Device Exemption(IDE) ](/terms/ide) - [Feasibility Study ](/terms/feasibility-study) You may also need Auto-suggested from Clinical & Trials and shared keywords. - [Investigator Brochure(IB) ](/terms/investigator-brochure) - [Adaptive Trial Design ](/terms/adaptive-trial) - [Bayesian Trial Design ](/terms/bayesian-trial) - [Investigator-Initiated Trial(IIT) ](/terms/investigator-initiated-trial) - [Real-World Data(RWD) ](/terms/rwd) - [Summative vs. Formative Evaluation ](/terms/summative-formative) [All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials) From the Blue Goat network Related resources and services on this topic. - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)